| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |